NASDAQ: SLXNW Silexion Therapeutics Corp 10-K

Silexion advances toward Q2 2026 trial start but faces ongoing cash crisis despite $18M raised

Filed March 17, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 18, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SLXNW commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.